Quinoline derivatives as alpha4beta7 integrin inhibitors

MYPI2025003621A0Undetermined Publication Date: 2020-04-30GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003621
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-03-26
Filing Date
2019-10-29
Publication Date
2020-04-30
Patent Text Reader

Abstract

QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS The present disclosure provides a compound of Formula (I): (I); or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
Need to check novelty before this filing date? Find Prior Art